Trial NCT02650635

View at ClinicalTrials.gov 
Org. Study IDs: MC1245
Secondary IDs: MC1245 NCI-2015-02150 P30CA015083

Last trial update was posted on 2018-09-05

MeSH Interventions

Cyclophosphamide Lenograstim

MeSH Conditions

Adenocarcinoma Breast Neoplasms Carcinoma Carcinoma, Non-Small-Cell Lung Carcinoma, Renal Cell Colorectal Neoplasms Melanoma Melanoma, Cutaneous Malignant Pancreatic Neoplasms Recurrence

Other Conditions

Colorectal Adenocarcinoma Metastatic Pancreatic Adenocarcinoma Recurrent Breast Carcinoma Recurrent Colorectal Carcinoma Recurrent Melanoma of the Skin Recurrent Non-Small Cell Lung Carcinoma Recurrent Pancreatic Carcinoma Recurrent Renal Cell Carcinoma Solid Neoplasm Stage IV Breast Cancer Stage IV Non-Small Cell Lung Cancer Stage IV Renal Cell Cancer Stage IV Skin Melanoma Stage IVA Colorectal Cancer Stage IVA Pancreatic Cancer Stage IVB Colorectal Cancer Stage IVB Pancreatic Cancer

Stopping Reasons

permanently closed per sponsor's request

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID